Statistics
Total Visits
Views | |
---|---|
Renal profile of patients treated with elvitegravir/ cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort | 76 |
Total Visits Per Month
September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Renal profile of patients treated with elvitegravir/ cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort | 8 | 0 | 0 | 9 | 6 | 4 | 3 | 3 | 4 | 5 | 7 |
File Visits
Views | |
---|---|
Rotea_Renal.pdf | 150 |
Top country views
Views | |
---|---|
United States | 45 |
China | 9 |
Sweden | 4 |
Germany | 3 |
Ireland | 3 |
Spain | 2 |
Argentina | 1 |
Netherlands | 1 |
Portugal | 1 |
Romania | 1 |
Top cities views
Views | |
---|---|
Menlo Park | 9 |
Boardman | 6 |
Fremont | 6 |
Hangzhou | 5 |
Fairfield | 4 |
Dublin | 3 |
A Coruña | 2 |
Ashburn | 2 |
San Diego | 2 |
Ann Arbor | 1 |